Alivus Life Sciences Ltd

We wish to inform you that the Company has intimated its designated persons regarding the closure of trading window from December 31 2024 to January 25 2025 (both days inclusive) for the purpose of approval of unaudited financial Results for the Third quarter and nine months ended 31st December 2024.